Summary: Limbus Contour offers automated contouring for radiation therapy, significantly reducing the time required for manual contouring of organs at risk (OARs) and clinical target volumes (CTVs). The software operates entirely on local workstations, eliminating the need for cloud transfers and ensuring patient data remains secure. With its extensive library of clinically validated anatomical structures, Limbus Contour integrates seamlessly into existing treatment planning systems, supporting a wide range of platforms without the need for specialized hardware.

Summary: DLCExpert automates the delineation and contouring of organs at risk (OARs) in radiation oncology, leveraging deep learning technology to enhance accuracy and consistency. This tool integrates into existing clinical workflows, offering a library of structures for various cancer types including head and neck, thorax, breast, and prostate. It aims to save time on manual contouring tasks, allowing clinicians to focus on complex cases and improve patient outcomes.

Summary: The GBS™ Suite by MVision AI encompasses Contour+, Verify, and Guide, three integrated tools designed to enhance radiotherapy planning and execution. Contour+ automates the delineation of organs-at-risk and lymph node areas, Verify provides a platform for contour assessment, and Guide offers a training environment for guideline adherence and contouring proficiency. This suite streamlines the treatment planning process, ensuring high-quality, guideline-compliant contours and improving efficiency in radiotherapy workflows.

Summary: WRDensity leverages artificial intelligence to provide a more consistent assessment of breast density during mammography screenings. It is designed to integrate seamlessly with RIS/PACS systems and has been trained on over 600,000 images from the Mallinckrodt Institute of Radiology. This tool aims to create uniformity in density assessment at the practice level, improving the accuracy of breast cancer screenings.

Summary: red dot® is an AI-powered diagnostic platform designed to enhance the accuracy and speed of diagnosing critical conditions through CT and X-ray imaging. It automatically identifies normal scans and prioritizes potential cases of lung cancer and acute findings in CT head exams for faster clinical decision-making. With a track record of analyzing over 32,000 patients without missing a single lung cancer case over three years, red dot® has demonstrated significant clinical validation and is approved by both the FDA and CE.

Summary: TeraRecon provides an advanced visualization and artificial intelligence (AI) platform designed to enhance medical imaging workflows. The platform integrates with existing systems to offer AI-driven insights and decision support across various specialties including radiology, cardiology, and neurology. It aims to improve patient care by accelerating time-to-treatment and enhancing diagnostic accuracy through the use of cutting-edge AI technologies.

Summary: Koios DS™ leverages artificial intelligence and machine learning to provide clinical decision support for the diagnosis of breast and thyroid cancer through ultrasound imaging. This software aims to improve diagnostic accuracy and efficiency, potentially leading to earlier detection and treatment. With FDA clearance and CE marking, Koios DS™ integrates into clinical workflows, offering a billable procedure that enhances both survival rates and workflow efficiency.

Summary: MAUI Imaging introduces an advanced ultrasound solution capable of imaging through obstacles such as bone, air, and metal, specifically designed for the brain. This FDA-cleared technology aims to revolutionize medical imaging by providing clear, real-time visuals for diagnosing and monitoring traumatic injuries, especially in environments where traditional imaging tools like CT scans are unavailable.

Summary: UltraSight offers AI-driven software that provides real-time guidance and quality assessment for healthcare professionals performing cardiac ultrasound. Designed to assist users regardless of their sonography proficiency, the tool enables the consistent performance of high-quality cardiac ultrasound across various settings, including clinics, community hospitals, and remote areas. This innovation aims to improve the accessibility, ease, and quality of cardiac imaging and diagnosis, facilitating more accurate and timely clinical decisions.

Summary: Hermia by Hermes Medical Solutions is a comprehensive, vendor-neutral software suite designed for nuclear medicine and molecular imaging. It integrates with all equipment and staff within a medical facility, aiming to optimize the potential of nuclear medicine departments. The software supports a wide range of clinical specialties, including advanced dosimetry tools, and offers scalability to meet future clinical needs.